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This paper reports an experimental comparison of artificial neural network (ANN) and support vector machine (SVM) ensembles
and their “nonensemble” variants for lung cancer prediction.These machine learning classifiers were trained to predict lung cancer
using samples of patient nucleotides with mutations in the epidermal growth factor receptor, Kirsten rat sarcoma viral oncogene,
and tumor suppressor p53 genomes collected as biomarkers from the IGDB.NSCLC corpus. The Voss DNA encoding was used to
map the nucleotide sequences of mutated and normal genomes to obtain the equivalent numerical genomic sequences for training
the selected classifiers.The histogram of oriented gradient (HOG) and local binary pattern (LBP) state-of-the-art feature extraction
schemes were applied to extract representative genomic features from the encoded sequences of nucleotides. The ANN ensemble
and HOG best fit the training dataset of this study with an accuracy of 95.90% and mean square error of 0.0159. The result of the
ANN ensemble and HOG genomic features is promising for automated screening and early detection of lung cancer. This will
hopefully assist pathologists in administering targeted molecular therapy and offering counsel to early stage lung cancer patients
and persons in at risk populations.
1. Introduction
The entire human cells, which depend heavily on regular and
adequate supply of oxygen to function effectively, may suffer
in the event of impairment in oxygen inflow. The lung is
the place where the required oxygen is taken in and excess
carbon-dioxide, which can be toxic to the body, is released.
Lungs purify air intake using cleaning systems, which destroy
harmful substances that travel in the air [1–3]. Cilia, the
tiny hairs that line the bronchi in the lungs have mucus,
which moves foreign objects such as bacteria and viruses
out and this provides the first defensive mechanism in the
lungs. However, because the lungs are delicate organs and
constantly exposed to the external environment, they are
prone to a range of illnesses generally referred to as lung
diseases. Some of these diseases are lung cancer, chronic
obstructive pulmonary disease, emphysema, asthma, chronic
bronchitis, pneumonia, pulmonary fibrosis, sarcoidosis, and
tuberculosis. Lung cancer develops as a result of a sustained
genetic damage to normal lung cells, which consequently lead
to an uncontrolled cell proliferation. It is also called bron-
chiogenic carcinoma and it mostly starts in the cells lining
the bronchi of the lungs [1]. Smoking is responsible for about
85% of lung cancer, but there are empirical evidences that
arsenic in water and beta-carotene supplement also increase
the predisposition to the disease. Other lung cancer carcino-
gens include asbestos, radon gas, arsenic, chromium, nickel,
polycyclic aromatic hydrocarbons, or genetic factor [4].
In classical oncology, lung cancer is named based on
how the cancerous cells look under a microscope. The two
major histological subtypes of lung cancers are small cell lung
cancer (SCLC), which is approximately 13% and non-small
cell lung cancer (NSCLC) that constitutes about 87% of the
disease. NSCLC subtype ismore dangerous because it spreads
more slowly than SCLC [5, 6]. Using the tissue, node, and
metastasis (TNM) classification system, NSCLC is divided
into four stages, which include Stage I, Stage II, Stage III, and
Stage IV. Stage III is the most sophisticated of the different
stages because it includes a tumor that has metastasized into
the chest wall, diaphragm, and pleura of the mediastinum
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or heart. It has mediastinum lymph node involvement and
it is often impossible to remove the cancerous tissues with
the degree of spread at this stage. The prognosis statistics of
NSCLC show that five-year overall survival of patients with
stage IA is 67% and for patients with stage IIA, it is 55%.
Patients with stage IIIA have 23% survival chance of five
years after surgery while patients with stage IV only have 1%
[5, 7, 8].
Lung cancer, like other cancers, is a highly complex and
heterogeneous genetic disease. Researchers have identified
two major categories of genes that suffer mutations and
genetic alterations of diverse kinds in lung cancer cells.
These categories are oncogenes and tumor suppressor genes.
Some examples of the oncogenes are epidermal growth
factor receptor (EGFR), Kirsten rat sarcoma viral oncogene
(KRAS), MYC, and BCL-2, and common examples of tumor
suppressor genes are tumor suppressor p53 (TP53) and
retinoblastoma (RB) [9–13]. As recent as 2013, Chen et al.
[14] carried out a study to identify genes that carry somatic
mutations of various types in lung cancer and reported 145
genes with high mutation frequencies. The study established
that the three most frequently mutated genes in lung cancer
are EGFR, KRAS, and TP53 with mutation frequencies
of 10957, 3106, and 2034, respectively. The authors further
posited that “these frequently mutated genes can be used to
design kits for the early detection of carcinogenesis”.
The classical equipment used for the detection and classi-
fication of lung tumors includes X-ray chest films, computer
tomography scans (CT), magnetic resonance imaging (MRI),
and Positron emission tomography (PET) [15]. The overall
identification of lung cancer images using this radiological
equipment is very low at the early stage of the disease [16].
This is because pathologists who interpret the radiological
scans do not sometimes differentiate accurately between
malignant, benign, and other forms of lesions in the lung.
However, with the landmark breakthrough in the complete
human genome sequencing study, there has been a gradual
shift from radiographic oncology to genomic-based cancer
detection [17].This trend is highly expected because all forms
of cancers emanate primarily from genomic abnormalities.
Molecular methods are therefore currently popular for
genetic screening of patients to detect somatic mutations in
lung cancer [18–21]. Direct sequencing of tumor sample is one
of the molecular methods frequently used, but this method
has been reported to have limitations such as low sensitivity,
low speed, and intensive labor requirement. Assays that are
based on quantitative real-time polymerase chain reaction
(PCR), fluorescence in situ hybridization (FISH), immuno-
histochemistry, and microarray technologies have also been
developed for detecting different classes of genomic defects.
Although someof these techniques have good sensitivity, they
are conversely limited in the degree of mutation coverage
[18, 22, 23].
The EGFR mutation testing is another method that has
been developed for lung cancer genetic test. This method is
acclaimed to have good capability formutation detection, but
it is also prone to several limitations such as low sensitivity,
longer turnaround time, high-quality tumor sample require-
ment, the need for expert experience, and limited coverage
of only EGFR mutations [24]. In light of the shortcomings
of the existing molecular testing methods, the authors in [18]
opined that “great number of molecular biologymethods and
variety of biological material acquired from patients create
a critical need for robust, well-validated diagnostic tests and
equipment that are both sensitive and specific to mutations.”
This study is inspired by the critical need to develop
equipment and/or models that can detect multiple mutations
in the early stage NSCLC. Our overarching objectives are
threefold. First, we want to leverage on the targeted sequenc-
ing (TS) capability of next generation sequencing (NGS) to
predict NSCLC. Rather than the whole genome sequencing
(WGS), which provides access to all genetic information
in coding, regulatory and intronic regions of an organism,
researchers are currently exploiting TS for genomic regions
that best address their questions. This is currently a huge
attraction for researchers in application niches such as cancer
genomics, which is also called oncogenomics, pharmacoge-
nomics, and forensic genomics [25].
Our second paramount objective is the adoption of the
Voss mapping encoding technique and the comparison of
histogram of oriented gradient (HOG) descriptor with local
binary pattern (LBP) descriptor for efficient extraction of
compact genomic features. The Voss mapping is reputed as
a spectrally efficient numerical encoding method in genomic
signal processing (GSP) research community whileHOG and
LBP are successful image descriptors for feature extraction in
the digital image processing (DIP) research domain [26, 27].
InDIG, shape and texture are important primitive features for
object description.TheHOG feature descriptor is nominated
for this study because it adequately captures the local appear-
ance and shape of an object [28]. On the other hand, the LBP
was considered for experimentation because of its capability
to properly describe the texture of an image [27, 29]. These
core characteristics of HOG and LBP are paramount for
detecting and discriminating the varying shapes and textures
of the Voss-mapped genomic features in this study.
Third, we want to experimentally compare multilay-
ered perceptron artificial neural network (MLP-ANN) and
support vector machine (SVM) ensembles as well as their
nonensemble variants for genomic-based prediction of
NSCLC using EGFR, KRAS, and TP53 Biomarkers. These
machine learning classifiers have been reported to be effective
in applications such as facial expression recognition, hyper-
spectral image processing, object detection, andBioinformat-
ics [30–32].
The computational approach being explored in this work
will apparently afford the opportunity of reconfiguration.
This will further allow us to incorporate additional somatic
mutations and other genetic abnormalities into the prediction
framework as new biomarkers and more mutation data
become available. The MATLAB scripts resulting from this
current work can potentially be interfaced with an NGS
equipment such as an IlluminaMiSeq sequencer to automate
NSCLC prediction from a targeted sequence.
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Figure 1: Architecture of the proposed NSCLC prediction model.
2. Materials and Methods
This section is a detailed report of the methods and materials
utilized in this study, beginning with the architecture of the
proposed NSCLC prediction model shown in Figure 1. The
different phases for implementing and utilizing the model
are presented as major blocks in Figure 1. The major blocks
in the architecture, which include data acquisition (genomic
database (DB) of mutated and normal genes), preprocess-
ing (numerical mapping of genomic nucleotides), feature
extraction, and classification are exhaustively discussed in
the subsequent subsections. The next generation sequencing
(NGS) block in the framework is an interface for entering test
genomic sequences into the prediction model.
2.1. Data Acquisition. The normal nucleotides of the three
genes in this study are extracts from the collaborative
consensus coding sequence (CCDS) archive in the National
Centre for Biotechnology Information (NCBI) repository.
The CCDS project compiles identical protein annotations on
the genomes of Homo sapiens (humans) and Mus musculus
(mouse) using a stable identifier tagged CCDS ID. The
purpose of the unique tagging is to remove the uncertainty
of sequences emanating from different laboratories using
different sequencing methods [33]. The CCDS IDs assigned
to EGFR, KRAS, and TP53 are CCDS5514.1, CCDS8702.1, and
CCDS11118.1, respectively. We used these IDs to extract the
normal nucleotides of genes from the online NCBI genome
Table 1: Normal gene characteristics.
S/N Gene symbol Number of nucleotides CCDS ID
1 EGFR 3633 CCDS 5514.1
2 KRAS 567 CCDS 8702.1
3 TP53 1182 CCDS 11118.1
Table 2: Mutation class characteristics.
S/N Mutation class Number ofacquired samples
Number of
unique samples
1 EGFR deletion 2640 35
2 EGFR substitution 975 27
3 KRAS substitution 2472 28
4 TP53 deletion 42 32
5 TP53 substitution 277 35
Total 6,406 157
repository. Mutation datasets for each of the genes were
collected from the Integrated Genomic Database of Non-
Small Cell Lung Cancer (IGDB.NSCLC), which is an online
corpus dedicated to the archiving of NSCLC genetic defects.
The somatic mutations in the corpus were, according to the
authors of IGDB.NSCLC corpus, imported from COSMIC
(Catalogue of Somatic Mutations in Cancer) database [34].
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Deletion and substitution mutation data were extracted
for both EGFR and TP53 because these two genetic events
were reported in the literature to be the most predominant
lung cancer somatic mutations [14, 35]. Moreover, we discov-
ered that 99.67% of KRAS mutations in the IGDB.NSCLC
database are substitution while deletion mutation data are
a negligible 0.00131%. Based on these statistics, KRAS sub-
stitution mutation is also selected for this study. Overall,
we acquired 6,406 samples and our experimental dataset
contains six different classes, which are normal, EGFR dele-
tion, EGFR substitution, KRAS substitution, TP53 deletion,
and TP53 substitution mutations. The general statistics of
the acquired data for both normal and mutated samples are
shown in Tables 1 and 2.
2.2. Numerical Mapping of Genomic Nucleotides. The selec-
tion of a mapping method for numeric encoding of genomic
sequence determines how the intrinsic properties and fea-
tures of interests for a given sequence are reflected and
exploited. The approaches for numerical encoding of DNA
sequences are classified into fixed mapping (FM) and physic-
ochemical property based mapping (PCPBM) [36]. The
PCPBM approach involves the use of biophysical and bio-
chemical properties of DNA molecules for sequence map-
ping. The methods in this category are applied in detect-
ing biological principles and structures in DNA. Examples
of PCPBM methods in the literature include electron-ion
interaction potential (EIIP), atomic number, paired numeric,
DNA walk, 𝑍-curve representation, molecular mass, and
paired nucleotide atomic number [37]. In FM approach,
nucleotide sequences are transformed into a series of binary,
real, or complex numerical sequences. Examples of FM
methods are Voss [38], tetrahedron [39], complex number
[40], integer numbers [41], real numbers [42], single Galois
indicator [43], quaternary code [44], and left-rotated quater-
nary code [37].
The Voss, which was named indicator sequence by the
proponent, is the first numerical mapping method for DNA
sequences [38]. The indicator sequence as defined by Voss
is a sequence in which adenine (A), cytosine (C), guanine,
(G) and thymine (T) nucleotides are mapped into four
binary sequences 𝑥
𝐴
(𝑘), 𝑥
𝐶
(𝑘), 𝑥
𝐺
(𝑘), and 𝑥
𝑇
(𝑘), where
1 at position 𝑘 indicates the presence of the base at that
position and 0 stands for its absence [38]. The Voss method
is very efficient for spectral analysis of nucleotide sequences
[36]. It was used in [45] for identification of exons and
introns in DNA sequences with appreciable success.TheVoss
method is applied in this work so as to capture the biological
knowledge that are inherent in genomic sequences and to
take advantage of the characteristics of the method such as
spectral efficiency and 2-dimensional matrix output. With
Voss numerical mapping method, there is a good prospect of
applying digital image processing (DIP) techniques to obtain
descriptors such as HOG and LBP for genomic sequences.
In DIP, an image is a two-dimensional function 𝑔(𝑖, 𝑗)
in which 𝑖 and 𝑗 are spatial coordinates. When 𝑖, 𝑗 and the
amplitude value that is the intensity of 𝑔 are finite, the image
Table 3: Voss mapping of the first ten EGFR gene nucleotides.
DNA
sequence A T G C G A C C C T. . .
𝑥
𝐴
(𝑘): 1 0 0 0 0 1 0 0 0 0
𝑥
𝐶
(𝑘): 0 0 0 1 0 0 1 1 1 0
𝑥
𝐺
(𝑘): 0 0 1 0 1 0 0 0 0 0
𝑥
𝑇
(𝑘): 0 1 0 0 0 0 0 0 0 1
Table 4: Voss mapping of the first ten KRAS gene nucleotides.
DNA
sequence A T G A C T G A A T. . .
𝑥
𝐴
(𝑘): 1 0 0 1 0 0 0 1 1 0
𝑥
𝐶
(𝑘): 0 0 0 0 1 0 0 0 0 0
𝑥
𝐺
(𝑘): 0 0 1 0 0 0 1 0 0 0
𝑥
𝑇
(𝑘): 0 1 0 0 0 1 0 0 0 1
Table 5: Voss mapping of the first ten TP53 gene nucleotides.
DNA
sequence A T G G A G G A G C. . .
𝑥
𝐴
(𝑘): 1 0 0 0 1 0 0 1 0 0
𝑥
𝐶
(𝑘): 0 0 0 0 0 0 0 0 0 1
𝑥
𝐺
(𝑘): 0 0 1 1 0 1 1 0 1 0
𝑥
𝑇
(𝑘): 0 1 0 0 0 0 0 0 0 0
is described as a digital image [46]. A𝑀×𝑁 digital grayscale
image can be represented in the matrix notation as
𝑔 (𝑖, 𝑗)=
[
[
[
[
𝑔 (0, 0) 𝑔 (0, 1) ⋅ ⋅ ⋅ 𝑔 (0,𝑁 − 1)
𝑔 (1, 0) 𝑔 (1, 1) ⋅ ⋅ ⋅ 𝑔 (1,𝑁 − 1)
⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ ⋅
𝑔 (𝑀 − 1, 0) 𝑔 (𝑀 − 1, 1) ⋅ ⋅ ⋅ 𝑔 (𝑀 − 1,𝑁 − 1)
]
]
]
]
.
(1)
Each of the elements of the digital image represented on
the right hand side of (1) is called a picture element or
pixel. Consequently, with the Voss numerical mapping of
genomic nucleotides, the value of zero or one at position
𝑘 of the four sequences 𝑥
𝐴
(𝑘), 𝑥
𝐶
(𝑘), 𝑥
𝐺
(𝑘), and 𝑋𝑇(𝑘)
represents the pixel intensity (gray level) at that position.The
resulting sequences are concatenated into a 4 × 𝑁 output
silhouettematrix similar to (1), where𝑁 is the total number of
bases in a given sequence. The Voss mapping procedure was
implemented in this study using the MATLAB R2012a. The
Voss mapped sequences for the first ten nucleotides of EGFR,
KRAS, and TP53 genes are shown in Tables 3, 4, and 5 for the
sake of lucidity.
Image representations for the sequences in Tables 3, 4,
and 5 were also obtained using the appropriate functions in
MATLABR2012a and sample outputs are, respectively, shown
in Figures 2(a), 2(b), and 2(c). The visual inspection of the
figures shows that the images of each of the biomarkers in
this study are unique. Hence, we should be able to seek for
their unique feature representation to aid efficient lung cancer
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Figure 2: (a) Image of the Voss mapped sequences for the first ten EGFR nucleotides. (b) Image of Voss mapped sequences for the first ten
KRAS nucleotides (c) Image of Voss mapped sequences for the first ten TP53 nucleotides.
prediction usingmachine learning classifiers such as artificial
neural networks and support vector machines.
2.3. Feature Extraction. The histogram of oriented gradi-
ent (HOG) descriptor is explored to extract representative
features from the images of the Voss encoded genomic
sequences in Section 2.2. The HOG technique, which was
developed by Dalal and Triggs [26] for human recognition, is
based on the principle that local object appearance and shape
in an image can be represented by the distribution of intensity
gradients or edge orientations. In order to implement HOG,
the image is first divided into cells and histogram of gradient
orientations are computed for the pixels within the cells.
The resulting histograms are then combined to represent the
image descriptor. However, to enhance the performance of
the descriptor, local histograms are contrast normalized by
computing a measure of intensity across a larger region of
the image called a block.The intensity values are then used to
normalize all cells within the block,which results in a descrip-
tor that has better invariance to illumination changes and
shadowing. There are four primary steps to compute HOG.
The first step involves the computation of the gradient
values, which can be done by applying the finite difference
approximation or derivative masks on the input image. The
1D centered point discrete derivative mask was shown by
Dalal and Triggs [26] to be better than Sobel operator and
diagonal masks. Using the 1D derivative mask, the input
image 𝐼 is filtered in both vertical and horizontal directions
with the kernels in
𝐷
𝑥
= [−1 0 1] ,
𝐷
𝑦
= [1 0 −1]
𝑇
,
(2)
where [⋅]𝑇 is a transpose vector. The 𝑥 and 𝑦 derivatives of
the silhouette or grayscale image 𝐼 are then obtained using
the convolution operation as
𝐼
𝑥
= 𝐼 ∗ 𝐷
𝑥
,
𝐼
𝑦
= 𝐼 ∗ 𝐷
𝑦
.
(3)
The magnitude and orientation of the gradient of 𝐼 are,
respectively, computed using the following:
|𝐺| = √𝐼
2
𝑥
+ 𝐼2
𝑦
, (4)
𝜃 = arctan(
𝐼
𝑦
𝐼
𝑥
) . (5)
The second step in the computation of HOG is called
orientation binning, which involves the creation of cell his-
tograms. HOG cells are rectangular (or circular, in some
real implementations) and the histogram channels are either
unsigned or signed. Signed histogram channels are spread
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over 0 to 180 degrees, while unsigned channels are spread
over 0 to 360 degrees. Using the value in the gradient
computation, each pixel within the cell casts a weighted vote
for an orientation-based histogram channel. Dalal and Triggs
[26] observed that the best experimental result of human
recognition was obtained by using unsigned histogram chan-
nel and an angular range of 20 degrees. The bin size for this
range is therefore 180/20 = 9 histogram channels.
The third step of HOG computation is the creation of
descriptor blocks. The cell orientation histograms are grouped
into larger and spatially connected blocks before they can be
normalized. This procedure is carried out so as to account
for changes in illumination and contrasts.There are currently
two types of geometries for the block, which are rectangular
(R-HOG) and circular (C-HOG). The R-HOG is typically
a square grid that can be described with the number of
cells/block, the number of pixels/cell, and the number of
channels/cell histogram. The blocks overlap each other for a
magnitude of half size of a block.
The final step in HOG computation is block normaliza-
tion. The normalization factor for a nonnormalized vector
(V) that contains the histogram in a given block is one of the
following norms:
L2-norm: 𝑓 = V
√‖V‖2
2
+ 𝑒2
,
L1-norm: 𝑓 = V
‖V‖1 + 𝑒
,
L1-sqrt: 𝑓 = √
V
‖V‖1 + 𝑒
,
(6)
where 𝑒 is a constant whose value will not influence the result.
Dalal and Triggs [26] observed in their human recognition
experiment that L2-norm and L1-sqrt methods produced
comparable performance while L1-norm performance is the
least. The HOG descriptor is therefore the vector, which
contains the normalized cell histograms from all the block
regions in the image. In this study, we have applied the
unsigned histogram channel and a bin size of 9, similar to the
studies in [26, 28] to process the genomic images obtained for
both normal andmutation sequences from the Voss mapping
procedure discussed in Section 2.2. With this nine-bin size,
nine consecutive blocks were then utilized to compute HOG
feature vector of size 81 each for all the imaged genomic
sequences.
The foregoing HOG algorithmic steps were implemented
in MATLAB R2012a. Using the results obtained from the
code, we plotted the time domain graph of the first samples
in each of the classes in our experimental dataset as shown in
Figure 3.This graph clearly and visibly shows unique patterns
for the different classes of mutations in our training dataset.
This is a strong proof of the discriminatory power of HOG
descriptor. Our second objective of using Voss mapping to
encode and HOG to extract representative genomic features
in this study has therefore been realized with the procedures
discussed in Section 2.2 and this section. Apart from the first
application of HOG descriptor for human recognition by
Dalal and Triggs [26], the method has also been used with
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Figure 3: Time domain plot of HOG features for the first samples
of EGFR deletion, EGFR substitution, KRAS substitution, TP53
substitution, and TP53 deletion mutations.
Table 6:Numerical representationwhich indicates the target output
of different classes.
S/N Class MLP-ANN targetoutput
SVM target
output
1 Normal(EGFR/KRAS/TP53) 1 0 0 0 0 0 1
2 EGFR deletion 0 1 0 0 0 0 2
3 EGFR substitution 0 0 1 0 0 0 3
4 KRAS substitution 0 0 0 1 0 0 4
5 TP53 deletion 0 0 0 0 1 0 5
6 TP53 substitution 0 0 0 0 0 1 6
good results in domains as diverse as activity recognition [28,
47], pedestrian detection [48], and speaker classification [49].
In order to automate the classification of different patterns
(mutation classes) captured by the HOG feature vectors in
this work, we designed and trained ensemble and nonensem-
ble artificial neural networks and support vector machines.
2.4. Classification Models. The classification model for
NSCLC in this study classifies an input genomic feature
vector into one of six classes in order to predict the presence
or absence of specific genomic mutations. Table 6 shows
the different classes in the framework and their numerical
representations, which indicate target or expected output
from the classification model for each class. Ensemble
and nonensemble multilayered perceptron artificial neural
network (MLP-ANN) and support vector machine (SVM)
are compared in order to make the choice of the most
appropriate classification model and to validate our results.
An artificial neural network (ANN) is a mathematical
model that simulates the structure and function of the
biological nervous system [50]. It is primarily composed
of orderly interconnected artificial neurons. The structure
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and functional elements of an artificial neuron, which is the
building block of all ANN systems, are shown in Figure 4.
As illustrated in Figure 4, an artificial neuron has a set of
𝑛 synapses associated with the inputs (𝑥
1
, . . . , 𝑥
𝑛
) and each
input has an associated weight (𝑤
𝑖
). A signal at input 𝑖 is
multiplied by the weight 𝑤
𝑖
, the weighted inputs are added
together, and a linear combination of the weighted inputs is
obtained. A bias (𝑤
0
), which is not associated with any input,
is added to the linear combination and a weighted sum 𝑧 is
obtained as
𝑧 = 𝑤
0
+ 𝑤
1
𝑥
1
+ ⋅ ⋅ ⋅ + 𝑤
𝑛
𝑥
𝑛
. (7)
Subsequently, a nonlinear activation function 𝑓 is applied to
the weighted sum in (7) and this produces an output 𝑦 shown
in
𝑦 = 𝑓 (𝑧) . (8)
The flexibility and ability of an artificial neuron to approx-
imate functions to be learned depend on its activation
function. Linear and sigmoid functions are some examples
of the activation functions frequently used in neural net-
work applications. The linear activation functions are mostly
applied in the output layer and it has the form:
𝑓 (𝑧) = 𝑧. (9)
The sigmoid activation functions are 𝑆-shaped and the ones
that are mostly used are the logistic and the hyperbolic
tangent as represented in (10) and (11), respectively,
𝑓 (𝑧) =
1
1 + 𝑒−𝑎𝑧
, (10)
𝑓 (𝑧) =
𝑒
𝑧
− 𝑒
−𝑧
𝑒𝑧 + 𝑒−𝑧
. (11)
One of the most commonly used artificial neural net-
works is the multilayer perceptron (MLP). The MLP is a
nonlinear neural network, which is made up of neurons
that are arranged in layers. Typically, MLP is composed of
a minimum of three layers, which comprises an input layer,
one or more hidden layers, and an output layer [51]. In this
study, an MLP topology was designed to learn the extracted
genomic features in Section 2.3. The choice of the number
of hidden layers is a vital decision to be considered when
designing MLP-ANNs. It was established in [52] that a net-
work with one hidden layer can approximate any continuous
W
b
+
W
b
+
Hidden layer 1 Hidden layer 2
Output
6
Input
81
Figure 5: Architecture of the MLP-ANN classifier.
functions. However, another study [53] has reported that, for
large problems, more hidden layers can lead to the training of
the network settling for few local minimums and reduction
of the network errors. On this basis, we decided to use two
hidden layers for the MLP in this study.
The choice of an appropriate activation function for the
neurons in the different layers of MLP is very crucial to the
performance of the network.The linear activation function is
generally used for the input neurons because it transmits the
input dataset directly to the next layer with no transforma-
tion. The choice of activation function for the output layer
neurons is a function of the problem being solved. In our
case, which is a multiclass learning problem, we decided to
select the hyperbolic tangent sigmoid function for the output
layer neurons because it has the capability to handle either
continuous values or 𝑛-class binary classification problems.
The hyperbolic tangent sigmoid function is also chosen
for the neurons in hidden layers because it is nonlinear
and differentiable. Differentiability and nonlinearity are vital
requirements for MLP training algorithms [53].
The training dataset for MLP usually consists of a set of
patterns (𝑥
𝑝
, 𝑡
𝑝
) where 𝑝 represents the number of patterns
and 𝑥
𝑝
is the 𝑁-dimensional input vector. Since each HOG
genomic feature vector in this study has 81 elements, 𝑁 is
equal to 81 and our 𝑥
𝑝
is 81-dimensional. Furthermore, 𝑡
𝑝
is
the target output vector for the𝑝 pattern and because we have
six different classes to be classified, we encoded each target
output using 6-element binary vector as shown in Table 6.
Hence, the MLP architecture in this work contains 81 neu-
rons in the input layer and 6 neurons in the output layer.
Based on the foregoing analytical decisions, we designed and
configured MLP-ANN in MATLAB R2012a and the resulting
network architecture is shown in Figure 5.
MLP neural networks are typically trained with back-
propagation (BP) algorithm. BP is an application of the
gradientmethod or other numerical optimizationmethods to
feed-forward ANN so as to minimize the network errors. It is
themost popularmethod for performing supervised learning
in ANN research community [54, 55]. There are different
variants of the BP algorithm, which include conjugate gra-
dient BP (CGB), scale conjugate gradient (SCG), conjugate
gradient BP with Polak-Riebre, conjugate gradient BP with
Fletcher-Revees updates, one-secant BP, resilient BP, Leven-
berg Marquardt (LM), gradient descent, quasi-Newton, and
many others [56]. Scaled conjugate gradient backpropagation
(SCG-BP) algorithm is a fully automated method, which was
designed to avoid the time consuming line search often used
in CGB and quasi-Newton BP algorithms [56]. We adopted
8 The Scientific World Journal
Table 7: Nonensemble MLP-ANN experimentation result with
varying number of hidden layer neurons using HOG features.
MLP-ANN Hidden layerneurons MSE Accuracy (%)
1 10 0.0605 75.1
2 20 0.0867 61.1
3 30 0.0380 71.5
4 40 0.0581 74.6
5 50 0.0439 80.3
6 60 0.0516 79.3
7 70 0.0614 78.8
8 80 0.0355 87.6
9 90 0.0604 75.6
10 100 0.0403 84.5
SCG-BP to train the designedMLP-ANN in this work so as to
take advantage of its well acclaimed speed of convergence [30,
57]. The number of neurons in the hidden layer of our MLP
was determined experimentally because there is currently no
precise rule of thumb for selecting the number of hidden layer
neurons [58]. The experimental procedure and the results we
obtained are detailed in Section 3.
3. Experimental Results and Discussion
The designed MLP-ANN was programmed using the neural
network toolbox in MATLAB R2012a. All the experiments
reported in this paper were performed on an Intel Core i5-
3210MCPU@ 2.50GHz speed with 6.00GB RAM and 64-bit
Windows 8 operating system. Although training algorithms
seek to minimize errors in neural networks, local minimum
is often amajor problem and one of the important approaches
in common use to address this problem is to vary the number
of neurons in the hidden layer until an acceptable accuracy is
achieved [53].The first experiment was therefore undertaken
to determine the appropriate number of neurons in the
hidden layer of our MLP-ANN architecture.
In the first experimental setup, the number of iterations
for training the network called epochs in ANN parlance was
set to 500. In order to eliminate the incidence of overfitting
that may happen, if the number of epochs is either too
small or too large, we configured the network to stop the
training when the best generalization is reached. This was
achieved by partitioning the HOG data into 70% training,
15%validation, and 15% testing subdataset.TheHOG training
set was used to train the network while the validation set was
used to measure the error and the network training stops,
when the error starts to increase for the validation dataset.
Furthermore, we varied the number of neurons in the hidden
layer from 10 in step of 10 to 100 and recorded themean square
errors (MSE) and accuracies (from the confusion matrix
plot) for each trial. Table 7 shows the MSE and accuracies
we obtained for the different networks with varying number
of neurons in the hidden layer. For the ten different ANN
configurations shown in Table 7, the 8th MLP-ANN gave the
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Figure 6: Confusion matrix for the best ANN in Table 7.
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Figure 7: Performance plot for the best ANN in Table 7.
best accuracy of 87.6%,MSE of 0.0355, and the best validation
performance of 0.0584 at 490 epochs. The confusion matrix
and the best performance plot of the 8th MLP-ANN are as
shown in Figures 6 and 7, respectively. A similar result of
87.2% accuracy was reported by the authors in [30] for a study
on the use of SCG-BP for face expression recognition.
From the result of the current experiment, we observed
that the performance of the MLP-ANN across each trial did
not show any progressive improvement as the number of
hidden layer neurons increased. This is illustrated with the
lower accuracies of 75.6% in the 9th network and 84.5% in
the 10th network. This result is a justification of our decision
to experimentally determine the appropriate number of
neurons in the hidden layer of the MLP-ANN.
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Table 8: Output of the nonensemble MLP-ANN on “seen” HOG genomics samples.
S/N Class name Actual output Target output Remark
1 Normal
EGFR 1 0 0 0 0 0 1 0 0 0 0 0 Correct prediction
KRAS 1 0 0 0 0 0 1 0 0 0 0 0 Correct prediction
TP53 0 0 0 0 1 0 1 0 0 0 0 0 Incorrect prediction
2 EGFR deletion 0 1 0 0 0 0 0 1 0 0 0 0 Correct prediction
3 EGFR substitution 0 0 1 0 0 0 0 0 1 0 0 0 Correct prediction
4 KRAS substitution 0 0 0 1 0 0 0 0 0 1 0 0 Correct prediction
5 TP53 deletion 0 0 0 0 1 0 0 0 0 0 1 0 Correct prediction
6 TP53 substitution 0 0 0 0 0 1 0 0 0 0 0 1 Correct prediction
Table 9: Output of the nonensemble MLP-ANN on “unseen” HOG genomic samples.
S/N Class names Actual output Target output Remark
1 EGFR deletion 0 1 0 0 0 0 0 1 0 0 0 0 Correct prediction
2 EGFR substitution 1 0 1 0 0 0 0 0 1 0 0 0 Incorrect prediction
3 KRAS substitution 1 0 0 0 0 0 0 0 0 1 0 0 Incorrect prediction
4 TP53 deletion 0 0 0 0 0 1 0 0 0 0 1 0 Incorrect prediction
5 TP53 substitution 0 0 0 0 1 0 0 0 0 0 0 1 Incorrect prediction
In order to further examine the efficacy of the 8th net-
work, which we adopted based on its performance measures,
we tested it with different samples of “seen” and “unseen”
HOG genomic features. The “seen” samples are features that
were included in the training dataset while the “unseen” sam-
ples are features that were not included in the training dataset.
The resultswe obtained are shown inTables 8 and 9.The result
in Table 8 shows that the trained ANN performed brilliantly
well when tested on “seen” sample dataset. However, despite
the reported accuracy of the 8th MLP-ANN, Table 9 result
shows that it performed very poorly on “unseen” dataset.
The implication of this result is that the network is overfitted
on the training dataset and its generalization capability is
very weak. This result is a confirmation of the general
criticism in the literature against ANN as a weak and an
unstable classifier. In agreement with our result in the current
experiment, the authors in [58, 59] also posit that unstable
classifiers such as neural network and decision trees always
have the problem of high error on test dataset.
However, studies in the literature have affirmed that per-
formance and stability of neural networks can be improved by
combining several neural networks, a concept that is known
as ensembling [59, 60]. Examples of ensemble methods in the
literature include bagging [59], boosting [61], and random
forests [62]. In [59], the author stated categorically that bag-
ging ensemble is one of the most effective methods of neural
networks combination of learning problems. Consequently,
we performed another experiment to determine the effect of
bagging ensemble on the performance and stability of the 8th
MLP-ANN that we adopted from the first experiment.
In the second experiment, we used the configurations of
the 8th MLP-ANN in the first experiment to form the base
classifiers of the MLP-ANN bagging ensemble. Bagging is an
Table 10: Result of base classifiers in theMLP-ANN ensemble using
HOG genomic samples.
Base MLP-ANN MSE Accuracy (%)
1 0.0170 95.9
2 0.0118 97.9
3 0.0232 94.8
4 0.0107 97.9
5 0.0088 97.9
6 0.0193 94.8
7 0.0215 95.3
8 0.0206 94.8
9 0.0157 95.9
10 0.0197 94.8
11 0.0165 95.9
12 0.0222 94.8
Total 0.1905 1150.7
Average 0.0159 95.9
abbreviation for bootstrap aggregation and it uses a statistical
resamplingmethod called bootstrapping to generatemultiple
training sets. Our training dataset 𝑥
𝑝
is bootstrapped to
form a resampled training set 𝑥
𝑝
(𝑠). The resampled dataset
is thereafter used to construct a classifier and this procedure
is repeated several times to obtain multiple classifiers, which
are then combined using an appropriate voting method. The
bagging ensemble procedure was implemented in MATLAB
R2012a in this study. Using the bagging ensemble imple-
mentation, we generated 50 different classifiers and selected
the 12 that have accuracies of approximately 95% and above.
Selecting the best quality classifiers from multiple ones was
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Table 11: Output of the MLP-ANN ensemble on “seen” HOG genomic samples.
S/N Class name Actual output Target output Remark
1 Normal
EGFR 1 0 0 0 0 0 1 0 0 0 0 0 Correct prediction
KRAS 1 0 0 0 0 0 1 0 0 0 0 0 Correct prediction
TP53 1 0 0 0 0 0 1 0 0 0 0 0 Correct prediction
2 EGFR deletion 0 1 0 0 0 0 0 1 0 0 0 0 Correct prediction
3 EGFR substitution 0 0 1 0 0 0 0 0 1 0 0 0 Correct prediction
4 KRAS substitution 0 0 0 1 0 0 0 0 0 1 0 0 Correct prediction
5 TP53 deletion 0 0 0 0 1 0 0 0 0 0 1 0 Correct prediction
6 TP53 substitution 0 0 0 0 0 1 0 0 0 0 0 1 Correct prediction
Table 12: Output of the MLP-ANN ensemble on “unseen” HOG genomic samples.
S/N Output class Actual output Target output Remark
1 EGFR deletion 0 1 0 0 0 0 0 1 0 0 0 0 Correct prediction
2 EGFR substitution 0 0 1 0 0 0 0 0 1 0 0 0 Correct prediction
3 KRAS substitution 0 0 0 1 0 0 0 0 0 1 0 0 Correct prediction
4 TP53 deletion 0 0 0 0 1 0 0 0 0 0 1 0 Correct prediction
5 TP53 substitution 1 0 0 0 0 0 0 0 0 0 0 1 Incorrect prediction
also applied to classification trees by the author in [63].
Plurality voting was then applied to the 12 classifiers to
obtain the ensemble output. In plurality voting, a prediction
is judged as an output, if it comes first in the number of votes
that are cast by the base classifiers of the ensemble [64].
In this second experiment, the accuracies and MSEs
obtained for the MLP-ANN 12 base classifiers ensemble are
shown in Table 10. The result in Table 10 shows an average
accuracy of 95.9% and an average MSE of 0.0159 for the
MLP-ANN ensemble. This performance is better than the
nonensemble MLP-ANN that gave an accuracy of 87.6% and
anMSE of about 0.0355 in our previous experiment. In order
to further validate the high performance of the MLP-ANN
ensemble and examine its level of stability, we tested it with
both “seen” and “unseen” HOG genomic samples.The results
obtained for the “seen” samples are shown in Table 11 while
Table 12 shows the result obtained for “unseen” samples. From
Table 11, it can be observed that all the “seen” samples were
correctly classified and from Table 12, it can be observed that
only one of the “unseen” samples was wrongly classified.
However, the results we obtained for nonensemble MLP-
ANN in Tables 8 and 9 showed that the nonensemble neural
network classifier wrongly classified only one “seen” sample
and was able to classify only one “unseen” sample correctly.
In the third experiment, we utilized local binary pattern
(LBP) descriptor as a feature extraction algorithm for the
Voss-mapped genomics dataset. The goal of this experiment
was to experimentally compare the performance of HOG
features used in the earlier experiments with LBP features.
This is to ascertain the most suitable features for genomic-
based lung cancer prediction. LBP is a nonparametricmethod
developed by Ojala et al. [27] for the extraction of local
spatial features from images. The theoretical definition of the
Table 13: Nonensemble MLP-ANN result with varying number of
hidden layer neurons using LBP genomic samples.
MLP-ANN Hidden layer neurons MSE Accuracy (%)
1 10 0.0667 74.1
2 20 0.0628 71.5
3 30 0.0693 74.6
4 40 0.0632 71.5
5 50 0.0623 76.2
6 60 0.0585 74.1
7 70 0.0616 71.5
8 80 0.0504 77.7
9 90 0.0530 80.3
10 100 0.0555 78.2
basic LBP [27, 29] is very simple, which forms the basis of
its reputation as a computationally efficient image texture
descriptor in the image processing research domain [65, 66].
TheMATLAB R2012a implementation of LBP algorithm was
applied to the encoded genomic dataset in this study to obtain
LBP features for the normal and mutated genomic samples.
Utilizing the same configuration of the nonensemble
MLP-ANN in the first experiment, we trained different ANNs
with the LBP features by varying the number of hidden layer
neurons from 10 to 100 in step of 10. The performance results
of different trials are shown in Table 13. As illustrated in the
table, the 9th MLP-ANN with 90 neurons in the hidden
layer gave the best performance results with an accuracy of
80.3% and MSE of 0.0530. The confusion matrix for this 9th
MLP-ANN is shown in Figure 8 and its outputs when tested
with “seen” and “unseen” LBP genomic samples are shown in
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Figure 8: Confusion matrix for the best ANN in Table 13.
Tables 14 and 15. As illustrated in Table 13, the nonensemble
MLP-ANN using LBP features generated poorer accuracy
of 80.3% and MSE value of 0.0530 compared to the result
in the first experiment in which 87.6% accuracy and MSE
of 0.0355 using HOG features were produced. In a similar
vein, the outputs in Table 14 show that two instances of
“seen” LBP samples were incorrectly classified while, in the
first experiment, only one instance of HOG samples was
incorrectly classified. Table 15, however, shows that, similar to
the output of the nonensembleMLP-ANNwithHOG features
in the first experiment, only one instance of “unseen” LBP
sample was correctly classified. These statistics apparently
show the superiority of HOG genomics features over LBP
genomic features and provide evidence that nonensemble
MLP-ANN trained with either HOG or LBP features is not
suitable for the prediction task in this study.
Furthermore, we followed the bagging ensemble proce-
dure in the second experiment to conduct a fourth experi-
ment. In this fourth experiment, we trained 50 base MLP-
ANNs using LBP features and combined the first 12 base
MLP-ANNs with the highest accuracies. The results in this
fourth experiment gave an average accuracy of 82.4% and
an average MSE of 0.0479 (as shown in Table 16). When the
MLP-ANN ensemble was tested with “seen” and “unseen”
LBP genomic samples, the results we obtained are shown
in Tables 17 and 18, respectively. As illustrated in Tables 17
and 18, two samples were misclassified out of eight “seen”
LBP samples while two samples were also misclassified out
of five “unseen” LBP samples. The second experiment in
which MLP-ANN ensemble was trained with HOG genomic
samples gave a better result (as shown in Tables 11 and 12)
than the results produced by MLP-ANN ensemble trained
with LBP genomic samples in the current experiment.
So far, in this section, we have performed four different
experiments and compared the performances of HOG and
LBP genomic features using both nonensemble MLP-ANN
and MLP-ANN ensemble. In order to achieve an elaborate
and rigorous comparison of methods for the prediction
problem at hand, we undertook further experimenting with
both nonensemble support vector machine (SVM) and SVM
ensemble classifiers using HOG and LBP genomic features.
SVM is a statistical classificationmethod developed by Cortis
and Vapnik at Bell Laboratories in 1992 [67]. It has become
very popular for supervised learning in fields such as data
mining, bioinformatics, and image processing because of
its high accuracy and ability to handle data with high
dimensionality. Although SVMwas first developed for binary
classification, it has been improved to cater for multiclass
classification by breaking down the multiclass problem into
groups of two-class problems [31]. The most common mul-
ticlass method used in SVM is one-against-all because it is
very efficient and simple [68]. This one-against-all method is
adopted for both the nonensemble and ensemble SVMs in the
subsequent set of experiments (i.e., experiments 5 and 6) in
this study using the implementation in MATLAB R2012a.
It has been established in the literature that SVM can
efficiently carry out a nonlinear classification if a good choice
of kernel functions is made in its design [32]. The fifth
experiment was therefore set up to determine the appropriate
kernel function for the SVM classifiers in this study using
HOG genomic features and also, to examine the performance
of both nonensemble SVM and SVM ensemble on HOG
genomic features. For this fifth experiment, we configured
the nonensemble SVMwith 20-fold cross-validation inwhich
80% of the HOG genomic samples were used as training
set and 20% were implicitly used for validation. In order
to determine the kernel function with the best performance
metrics for the nonensemble SVM, we tested five different
kernel functions, namely, linear, quadratic, polynomial, radial
basis function (RBF), and multilayer perceptron (MLP) [32].
The performance results we obtained are shown in Table 19.
From Table 19, the polynomial kernel function gave the
best accuracy of 86.5% and MSE of 0.0706. The polynomial
kernel function was therefore adopted as the kernel function
for the SVM classifier in the current experiment. Table 20
shows the confusion matrix obtained from the properly con-
figured nonensemble SVM, trained with HOG genomic fea-
tures.The outputs obtained by testing the trained nonensem-
ble SVM in the current experiment using “seen” and “unseen”
HOG samples are shown in Tables 21 and 22, respectively.
As shown in Tables 21 and 22, all the “seen” samples were
correctly classified while two out of the five “unseen” samples
were misclassified. This result is an improvement over the
result obtained in the first experiment in which nonensemble
MLP-ANN misclassified four out of five “unseen” samples.
The result in the current experiment further validates the
claim in the literature that single SVM has better generaliza-
tion capability than single neural network [32].
The nonensemble SVM configuration in the current
experiment was further utilized to produce SVM ensemble
classifier using the bucket-of-models ensemble method. In
the bucket-of-models ensemble, the classification result of
the best model in the bucket for the problem being solved
is often selected [69]. The HOG genomic features were used
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Table 14: Output of the nonensemble MLP-ANN on “seen” LBP genomic samples.
S/N Class name Actual output Target output Remark
1 Normal
EGFR 1 0 0 0 0 0 1 0 0 0 0 0 Correct prediction
KRAS 1 0 0 0 0 0 1 0 0 0 0 0 Correct prediction
TP53 0 0 0 0 0 0 1 0 0 0 0 0 Incorrect prediction
2 EGFR deletion 0 1 0 0 0 0 0 1 0 0 0 0 Correct prediction
3 EGFR substitution 0 0 1 0 0 0 0 0 1 0 0 0 Correct prediction
4 KRAS substitution 1 0 0 0 0 0 0 0 0 1 0 0 Incorrect prediction
5 TP53 deletion 0 0 0 0 1 0 0 0 0 0 1 0 Correct prediction
6 TP53 substitution 0 0 0 0 0 1 0 0 0 0 0 1 Correct prediction
Table 15: Output of the nonensemble MLP-ANN on “unseen” LBP genomic samples.
S/N Class names Actual output Target output Remark
1 EGFR deletion 0 1 0 0 0 0 0 1 0 0 0 0 Correct prediction
2 EGFR substitution 1 0 0 0 0 0 0 0 1 0 0 0 Incorrect prediction
3 KRAS substitution 1 0 0 0 0 0 0 0 0 1 0 0 Incorrect prediction
4 TP53 deletion 0 0 0 0 0 1 0 0 0 0 1 0 Incorrect prediction
5 TP53 substitution 0 0 0 0 0 0 0 0 0 0 0 1 Incorrect prediction
Table 16: Result of base classifiers in MLP-ANN ensemble using
LBP genomic samples.
Base MLP-ANN MSE Accuracy (%)
1 0.0479 87.0
2 0.0464 81.3
3 0.0513 81.3
4 0.0450 82.9
5 0.0446 79.8
6 0.0496 80.3
7 0.0462 81.3
8 0.0522 80.8
9 0.0449 82.9
10 0.0501 79.8
11 0.0491 83.9
12 0.0476 87.6
Total 0.5749 988.9
Average 0.0479 82.4
to train 50 base SVMs to obtain an SVM ensemble classifier
and the best model in the ensemble gave an accuracy of 91.9%
with MSE of 0.0692. The outputs obtained when the SVM
ensemble was tested with “seen” and “unseen” HOG genomic
samples are shown in Tables 23 and 24. The results in Tables
23 and 24 show that all the “seen” samples were correctly
classified while two out of the five “unseen” samples were
misclassified. These results imply that SVM ensemble does
not have a radical improvement over the nonensemble SVM.
However, comparing the current result with the result in the
second experiment, theMLP-ANN ensemble performs better
than SVMensemble using theHOGgenomic datasets to train
the two ensemble classifiers.
The sixth experiment, which is the last in this study, was
targeted at examining the performance of nonensemble and
ensemble SVM on LBP genomic features. The first step we
took to achieve this objective was to test the five different
kernel functions so as to determine the best one for a
nonensemble SVM using LBP genomic features. Using 20-
fold cross-validation in which 80% of the LBP samples were
used for training and 20% utilized for validation, the per-
formance result we obtained is shown in Table 25. The table
shows that the polynomial kernel gave the best performance
with an accuracy of 75.7% and MSE of 0.0785. The confusion
matrix obtained from the nonensemble SVM trained with
LBP features in the current experiment is shown in Table 26
and the outputs when tested with “seen” and “unseen” LBP
features are shown in Tables 25 and 26. The results obtained
in the current experiment are not as good aswhatwe obtained
in the fifth experiment in which polynomial kernel function
gave an accuracy of 86.5% andMSEof 0.0691 for a nonensem-
ble SVM trained with HOG genomic features. Moreover, in
Tables 27 and 28, three out of eight samples weremisclassified
in the “seen” LBP samples while one out of five samples was
misclassified in the “unseen” LBP samples. On a general basis,
the result in the current experiment is not as good as the result
we obtained in the fifth experiment in which nonensemble
SVM was trained with HOG genomic features.
In furtherance of the realization of the objectives of the
current experiment, we utilized the same ensemble strategy
in the fifth experiment to train 50 base SVMs using LBP
features to obtain SVM ensemble. The model with the best
performance in the SVM ensemble gave an accuracy of 75.7%
and MSE of 0.0743. The outputs we obtained from the SVM
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Table 17: Output of the MLP-ANN ensemble on “seen” LBP genomic samples.
S/N Class name Actual output Target output Remark
1 Normal
EGFR 1 0 0 0 0 0 1 0 0 0 0 0 Correct prediction
KRAS 0 0 0 1 0 0 1 0 0 0 0 0 Incorrect prediction
TP53 0 0 0 0 0 0 1 0 0 0 0 0 Incorrect prediction
2 EGFR deletion 0 1 0 0 0 0 0 1 0 0 0 0 Correct prediction
3 EGFR substitution 0 0 1 0 0 0 0 0 1 0 0 0 Correct prediction
4 KRAS substitution 0 0 0 1 0 0 0 0 0 1 0 0 Correct prediction
5 TP53 deletion 0 0 0 0 1 0 0 0 0 0 1 0 Correct prediction
6 TP53 substitution 0 0 0 0 0 1 0 0 0 0 0 1 Correct prediction
Table 18: Output of the MLP-ANN ensemble on “unseen” LBP genomics samples.
S/N Output class Actual output Target output Remark
1 EGFR deletion 0 1 0 0 0 0 0 1 0 0 0 0 Correct prediction
2 EGFR substitution 1 0 0 0 0 0 0 0 1 0 0 0 Incorrect prediction
3 KRAS substitution 0 0 0 1 0 0 0 0 0 1 0 0 Correct prediction
4 TP53 deletion 0 0 0 0 1 0 0 0 0 0 1 0 Correct prediction
5 TP53 substitution 0 0 0 0 1 0 0 0 0 0 0 1 Incorrect prediction
Table 19: Nonensemble SVM experimentation result with varying
kernel functions using HOG genomic samples.
S/N Kernel function MSE Accuracy (%)
1 Linear 0.0825 67.6
2 Quadratic 0.0735 81.1
3 Polynomial 0.0706 86.5
4 RBF 0.0709 78.4
5 MLP 0.0926 40.5
Table 20: Confusionmatrix of the nonensemble SVMwith polyno-
mial kernel function using HOG genomic samples.
a b c d e f Classified as
7 0 0 0 0 0 a = normal
0 7 0 0 0 0 b = EGFR deletion
1 0 4 0 0 0 c = EGFR substitution
1 0 0 4 0 0 d = KRAS substitution
1 0 0 0 5 0 e = TP53 deletion
2 0 0 0 0 5 f = TP53 substitution
ensemble on both “seen” and “unseen” LBP genomic samples
are shown in Tables 29 and 30. As illustrated in Tables 29 and
30, three out of eight “seen” LBP samples were misclassified
while one out of five “unseen” samples was misclassified. The
general results obtained in the fifth experiment from SVM
ensemble trained with HOG genomic samples are better than
the results of the SVM ensemble with LBP genomic samples
in the current experiment.
So far, in this section, we havemeticulously experimented
with different classifiers and features extraction algorithms
Table 21: Output of the nonensemble SVMon “seen”HOGgenomic
samples.
S/N Class name Actualoutput
Target
output Remark
1 Normal
EGFR 1 1 Correct prediction
KRAS 1 1 Correct prediction
TP53 1 1 Correct prediction
2 EGFR deletion 2 2 Correct prediction
3 EGFR substitution 3 3 Correct prediction
4 KRAS substitution 4 4 Correct prediction
5 TP53 deletion 5 5 Correct prediction
6 TP53 substitution 6 6 Correct prediction
Table 22: Output of the nonensemble SVM on “unseen” HOG
genomic samples.
S/N Output class Actualoutput
Target
output Remark
1 EGFR deletion 2 2 Correct prediction
2 EGFR substitution 1 3 Incorrect prediction
3 KRAS substitution 1 4 Incorrect prediction
4 TP53 deletion 5 5 Correct prediction
5 TP53 substitution 6 6 Correct prediction
so as to arrive at a robust decision on the choice of models
for the lung cancer prediction framework being proposed in
this study. Hence, the summary of the accuracies andMSEs of
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Table 23: Output of the SVM ensemble on “seen” HOG genomic
samples.
S/N Class name Actualoutput
Target
output Remark
1 Normal
EGFR 1 1 Correct prediction
KRAS 1 1 Correct prediction
TP53 1 1 Correct prediction
2 EGFR deletion 2 2 Correct prediction
3 EGFR substitution 3 3 Correct prediction
4 KRAS substitution 4 4 Correct prediction
5 TP53 deletion 5 5 Correct prediction
6 TP53 substitution 6 6 Correct prediction
Table 24: Output of the SVM ensemble on “unseen” HOG genomic
samples.
S/N Output class Actualoutput
Target
output Remark
1 EGFR deletion 2 2 Correct prediction
2 EGFR substitution 6 3 Incorrect prediction
3 KRAS substitution 6 4 Incorrect prediction
4 TP53 deletion 5 5 Correct prediction
5 TP53 substitution 6 6 Correct prediction
Table 25: Nonensemble SVM result with varying kernel functions
using LBP genomic samples.
S/N Kernel function MSE Accuracy (%)
1 Linear 0.0945 43.2
2 Quadratic 0.0883 56.8
3 Polynomial 0.0785 75.7
4 RBF 0.0897 43.2
5 MLP 0.0871 18.9
Table 26: Confusionmatrix of the nonensemble SVMwith polyno-
mial kernel function using LBP genomic samples.
a b c d e f Classified as
5 0 0 0 2 0 a = normal
0 7 0 0 0 0 b = EGFR deletion
0 0 5 0 0 0 c = EGFR substitution
0 0 0 5 0 0 d = KRAS substitution
0 0 0 0 6 0 e = TP53 deletion
0 0 0 0 7 0 f = TP53 substitution
the different combinations of classifiers and feature extraction
methods in the foregoing experiments are shown in Table 31.
As shown in Table 31, the result in the second experiment
in which an accuracy of 95.9 andMSE of 0.0159 was obtained
provides a strong validation of the ability of MLP-ANN
ensemble to give high performance and high stability on the
test dataset of HOG genomic features. Based on this level
Table 27: Output of the nonensemble SVM on “seen” LBP genomic
samples.
S/N Class name Actualoutput
Target
output Remark
1 Normal
EGFR 1 1 Correct prediction
KRAS 1 1 Correct prediction
TP53 5 1 Incorrect prediction
2 EGFR deletion 2 2 Correct prediction
3 EGFR substitution 3 3 Correct prediction
4 KRAS substitution 1 4 Incorrect prediction
5 TP53 deletion 5 5 Correct prediction
6 TP53 substitution 5 6 Incorrect prediction
Table 28: Output of nonensemble SVM on “unseen” LBP genomic
samples.
S/N Output class Actualoutput
Target
output Remark
1 EGFR deletion 2 2 Correct prediction
2 EGFR substitution 3 3 Correct prediction
3 KRAS substitution 4 4 Correct prediction
4 TP53 deletion 5 5 Correct prediction
5 TP53 substitution 5 6 Incorrect prediction
Table 29: Output of the SVM ensemble on “seen” LBP genomic
samples.
S/N Class name Actualoutput
Target
output Remark
1 Normal
EGFR 1 1 Correct prediction
KRAS 1 1 Correct prediction
TP53 5 1 Incorrect prediction
2 EGFR deletion 2 2 Correct prediction
3 EGFR substitution 3 3 Correct prediction
4 KRAS substitution 1 4 Incorrect prediction
5 TP53 deletion 5 5 Correct prediction
6 TP53 substitution 5 6 Incorrect prediction
Table 30: Output of the SVM ensemble on “unseen” LBP genomic
samples.
S/N Output class Actualoutput
Target
output Remark
1 EGFR deletion 2 2 Correct prediction
2 EGFR substitution 3 3 Correct prediction
3 KRAS substitution 4 4 Correct prediction
4 TP53 deletion 5 5 Correct prediction
5 TP53 substitution 1 6 Incorrect prediction
of performance compared to the other models shown in
Table 31, the MLP-ANN ensemble is recommended as the
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Table 31: Summary of experimental results.
S/N Classifier/features extractionalgorithm Accuracy (%) MSE
1 Nonensemble MLP-ANN/HOG 87.6 0.0355
2 MLP-ANN ensemble/HOG 95.9 0.0159
3 Nonensemble MLP-ANN/LBP 80.3 0.0530
4 MLP-ANN ensemble/LBP 82.4 0.0479
5 Nonensemble SVM/HOG 86.5 0.0706
6 SVM ensemble/HOG 91.9 0.0692
7 Nonensemble SVM/LBP 75.7 0.0785
8 SVM ensemble/LBP 75.7 0.0743
classifier and HOG as the feature descriptor in the NSCLC
prediction framework being proposed in this study. The
result, we obtained in this work, is also in conformity with
the study on lung cancer cell identification based on artificial
neural network ensemble [70], where the images of the
specimen of needle biopsies were obtained from patients as
the dataset. The single ANN in [70] gave a poor average
error of 45.5% and neural network ensemble-based detection
(NED) system proposed in the study gave an average error of
11.6% as reported [70].
4. Conclusion
In this paper, we propose artificial neural network ensemble
with histogram of oriented gradient genomic features for
lung cancer prediction. The proposed framework has sev-
eral advantages, which include automated prediction using
artificial neural network ensemble, multiple biomarkers for
lung cancer on a single platform, compliance with NGS
genomic-based technology, and high prediction accuracy.
The performance comparison of the proposed framework
with support vector machine and local binary pattern is
valuable for decision makers to consider tradeoffs in method
accuracy versus method complexity. In the future, we hope to
incorporate more biomarkers on the proposed platform and
carry out further intensive comparative studies using other
state-of-the-art machine learning algorithms and features
extraction methods.
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